Genesis Healthcare, Inc. GENNQ
—
0.00
0.00
NaN
as of 24 Sep
- Market cap
- —
- P/E
- 0.0×
Follow GENNQ
| Older periods | Dec '20 | Mar '21 | Jun '21 | Sep '21 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
5.25% | 11.08% | 2.87% | (8.12%) | |
| (1.35%) | (3.03%) | (0.83%) | 2.45% | ||
ROIC |
(275.01%) | (297.91%) | (90.53%) | (25.67%) | |
Return on Tangible Assets |
2.96% | 6.73% | 2.45% | (7.90%) | |
Average Days of Receivables |
39.89 | 40.11 | 37.42 | 40.87 | |
Free Cash Flow per Share |
2.79 | 2.34 | (0.27) | 1.46 | |
Free Cash Flow |
312.32 | 266.57 | (32.49) | 176.38 | |
Capital Expenditures |
(3.41) | 15.03 | 18.54 | 218.14 | |
Piotroski F-Score |
2.00 | 2.00 | 0.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
44.16% | 44.08% | (7.42%) | (6.43%) | |
Accounts Receivable Turnover |
7.86 | 7.72 | 8.65 | 8.13 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.03) | (0.01) | (0.03) | 0.01 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
71.62% | 73.18% | 69.89% | 69.07% | |
Share Based Compensation of Revenue |
0.17% | 0.17% | 0.16% | 0.13% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(5.35) | (2.01) | 1.63 | (0.47) | |
Depreciation/Fixed assets |
0.11 | 0.13 | 0.14 | 0.14 | |
Capex/Depreciation |
(0.03) | 0.12 | 0.14 | 1.70 | |
Revenue per Share |
34.92 | 32.57 | 30.08 | 28.17 | |
Operating CF per Share |
2.82 | 2.21 | (0.43) | (0.35) | |
Capex per Share |
(0.03) | 0.13 | 0.16 | 1.81 | |
Capex to Sales |
0.00 | 0.00 | (0.01) | (0.06) | |
Net Profit Margin |
(1.51%) | (3.36%) | (0.88%) | 2.60% |
Columns are period end dates